Sun Pharmaceutical Industries Ltd said on Tuesday that the Food and the Drug Administration (FDA) had suspended its application for an experimental dermatological drug due to the possibility of thrombosis. Further developments are awaited.
Sun Pharmaceutical Industries Ltd said on Tuesday that the Food and the Drug Administration (FDA) had suspended its application for an experimental dermatological drug due to the possibility of thrombosis. Further developments are awaited.
